切换至 "中华医学电子期刊资源库"
高级检索
中华诊断学电子杂志

中华诊断学电子杂志 ›› 2024, Vol. 12 ›› Issue (01) : 64 -68. doi: 10.3877/cma.j.issn.2095-655X.2024.01.011

综述

Eph/Ephrin信号转导途径介导的生物学功能及其相关疾病的研究进展
常红敏1, 朱国强2, 李传宝2,†()   
  1. 1. 272013　济宁医学院临床医学院
    2. 272029　济宁医学院附属医院眼科
  • 收稿日期:2023-02-07 出版日期:2024-02-26
  • 通信作者: 李传宝
  • 基金资助:
    山东省自然科学基金(ZR2020QH149)

Research progress on the biological functions and related diseases mediated by the Eph/Ephrin signal transduction pathways

Hongmin Chang1, Guoqiang Zhu2, Chuanbao Li2,†()   

  1. 1. College of Clinical Medicine, Jining Medical University, Jining 272013, China
    2. Department of Ophthalmology, the Affiliated Hospital of Jining Medical University, Jining 272029, China
  • Received:2023-02-07 Published:2024-02-26
  • Corresponding author: Chuanbao Li
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

常红敏, 朱国强, 李传宝. Eph/Ephrin信号转导途径介导的生物学功能及其相关疾病的研究进展[J]. 中华诊断学电子杂志, 2024, 12(01): 64-68.

Hongmin Chang, Guoqiang Zhu, Chuanbao Li. Research progress on the biological functions and related diseases mediated by the Eph/Ephrin signal transduction pathways[J]. Chinese Journal of Diagnostics(Electronic Edition), 2024, 12(01): 64-68.

促红细胞生成素诱导肝细胞(Eph)受体是已知的酪氨酸蛋白激酶受体(RTKs)家族中最大的一类受体，在个体发育过程和多种疾病进程中发挥重要作用。一方面，Eph受体与其膜结合配体(Ephrin)的相互作用介导了胚胎发育到成人的一系列生理和病理过程；另一方面，Eph受体在与病原相关模式分子结合后，可参与机体感染与免疫，促进相关疾病的发生与发展。笔者就近年来Eph/Ephrin信号转导途径介导的生物学功能及相关疾病的最新研究进展进行综述，并总结Eph受体和Ephrin配体在神经系统、血管生成、肿瘤生成以及机体感染与免疫中的作用。

关键词: 受体，Eph家族, 膜附着型配体, 信号转导途径, 生物学功能

Erythropoietin-producing hepatocyte (Eph) receptor is the largest receptors among the known receptor tyrosine kinase (RTKs) family. The Eph receptor plays an important role in human ontogeny and various disease development. On the one hand, the interaction between the Eph receptor and its membrane binding ligand (Ephrin) mediates a range of physiological and pathological processes spanning from embryonic development to adulthood. On the other hand, the Eph receptor can contribute to infection and immunity by binding to pathogen-related model molecules, mediating the occurrence and development of associated diseases. This article reviews the latest research progress on the biological functions and related diseases mediated by the Eph/Ephrin signal transduction pathways in recent years and summarizes the role of the Eph receptor and Ephrin in the nervous system, angiogenesis, tumor development, infection, and immunity.

Key words: Receptors, Eph family, Ephrin, Signal transduction pathway, Biological function
[1]
Vreeken D, Zhang H, van Zonneveld AJ, et al.Ephs and Ephrins in adult endothelial biology[J].Int J Mol Sci，2020，21(16)：5623.DOI：10.3390/ijms21165623.
[2]
de Boer E, van Gils JM, van Gils MJ.Ephrin-Eph signaling usage by a variety of viruses[J].Pharmacol Res，2020(159)：105038.DOI：10.1016/j.phrs.2020.105038.
[3]
Adu-Gyamfi EA, Czika A, Liu TH, et al.Ephrin and Eph receptor signaling in female reproductive physiology and pathology[J].Biol Reprod，2021，104(1)：71-82.DOI：10.1093/biolre/ioaa171.
[4]
Sahoo AR, Buck M．Structural and functional insights into the transmembrane domain association of Eph receptors[J].Int J Mol Sci，2021，22(16)：8593.DOI：10.3390/ijms22168593.
[5]
刘正，邵子玮，袁文华，等．Eph/ephrin信号通路与神经干细胞的增殖和分化[J].中国组织工程研究，2019，23(13)：2101-2106.DOI：10.3969/j.issn.2095-4344.1654.
[6]
Pasquale EB.Eph receptors and ephrins in cancer：bidirectional signalling and beyond[J].Nat Rev Cancer，2010，10(3)：165-180.DOI：10.1038/nrc2806.
[7]
Darling TK, Lamb TJ.Emerging roles for eph receptors and ephrin ligands in immunity [J].Front Immunol，2019(10)：1473.DOI：10.3389/fimmu.2019.01473.
[8]
Kania A, Klein R．Mechanisms of ephrin-Eph signalling in development，physiology and disease[J].Nat Rev Mol Cell Biol，2016，17(4)：240-256.DOI：10.1038/nrm.2015.16.
[9]
Wu B, Rockel JS, Lagares D, et al.Ephrins and eph receptor signaling in tissue repair and fibrosis [J].Curr Rheumatol Rep，2019，21(6)：23.DOI：10.1007/s11926-019-0825-x.
[10]
Liang LY, Patel O, Janes PW, et al.Eph receptor signalling：from catalytic to non-catalytic functions[J].Oncogene，2019，38(39)：6567-6584.DOI：10.1038/s41388-019-0931-2.
[11]
Cayuso J, Dzementsei A, Fischer JC, et al.Ephrinb1/Ephb3b coordinate bidirectional epithelial-mesenchymal interactions controlling liver morphogenesis and laterality[J].Dev Cell，2016，39(3)：316-328.DOI：10.1016/j.devcel.2016.10.009.
[12]
Gong J, Körner R, Gaitanos L, et al.Exosomes mediate cell contact-independent ephrin-Eph signaling during axon guidance[J].J Cell Biol，2016，214(1)：35-44.DOI：10.1083/jcb.201601085.
[13]
Buckens OJ, El Hassouni B, Giovannetti E, et al.The role of Eph receptors in cancer and how to target them：novel approaches in cancer treatment[J].Expert Opin Investig Drugs，2020，29(6)：567-582.DOI：10.1080/13543784.2020.1762566.
[14]
Nikas I, Ryu HS, Theocharis S．Viewing the Eph receptors with a focus on breast cancer heterogeneity[J].Cancer Lett，2018(434)：160-171.DOI：10.1016/j.canlet.2018.07.030.
[15]
Cramer KS, Miko IJ.Eph-ephrin signaling in nervous system development[J].F1000Res，2016(5)：F1000 Faculty Rev-413 [pii].DOI：10.12688/f1000research.7417.1.
[16]
Egea J, Klein R．Bidirectional Eph-ephrin signaling during axon guidance[J].Trends Cell Biol，2007，17(5)：230-238.DOI：10.1016/j.tcb.2007.03.004.
[17]
Bochenek ML, Dickinson S, Astin JW, et al.Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding[J].J Cell Sci，2010，123(Pt 8)：1235-1246.DOI：10.1242/jcs.061903.
[18]
Elorriaga V, Pierani A, Causeret F. Cajal-retzius cells：recent advances in identity and function[J].Curr Opin Neurobiol，2023(79)：102686.DOI：10.1016/j.conb.2023.102686.
[19]
Niethamer TK, Bush JO. Getting direction(s): the Eph/ephrin signaling system in cell positioning[J].Dev Biol，2019，447(1)：42-57.DOI：10.1016/j.ydbio.2018.01.012.
[20]
Wan Y, Yang JS, Xu LC, et al.Roles of Eph/ephrin bidirectional signaling during injury and recovery of the central nervous system[J].Neural Regen Res，2018，13(8)：1313-1321.DOI：10.4103/1673-5374.235217.
[21]
Yang JS, Wei HX, Chen PP, et al.Roles of Eph/ephrin bidirectional signaling in central nervous system injury and recovery[J].Exp Ther Med，2018，15(3)：2219-2227.DOI：10.3892/etm.2018.5702.
[22]
Yang J, Luo X, Huang X, et al.Ephrin-A3 reverse signaling regulates hippocampal neuronal damage and astrocytic glutamate transport after transient global ischemia[J].J Neurochem，2014，131(3)：383-394.DOI：10.1111/jnc.12819.
[23]
Kaczmarek R, Gajdzis P, Gajdzis M．Eph receptors and ephrins in retinal diseases [J].Int J Mol Sci，2021，22(12)：6207.DOI：10.3390/ijms22126207.
[24]
Chen Y, Zhang H, Zhang Y．Targeting receptor tyrosine kinase EphB4 in cancer therapy[J].Semin Cancer Biol，2019(56)：37-46.DOI：10.1016/j.semcancer.2017.10.002.
[25]
Piffko A, Uhl C, Vajkoczy P, et al.EphrinB2-EphB4 signaling in neurooncological disease[J].Int J Mol Sci，2022，23(3)：1679.DOI：10.3390/ijms23031679.
[26]
Coucha M, Barrett AC, Bailey J, et al.Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents[J].Vascul Pharmacol，2020(131)：106761.DOI：10.1016/j.vph.2020.106761.
[27]
Zhou X, Tu P, Chen X, et al.Eph receptors：actors in tumor microenvironment [J].Crit Rev Oncog，2017，22(5/6)：499-505.DOI：10.1615/CritRevOncog.2017020557.
[28]
Nakayama A, Nakayama M, Turner CJ, et al.Ephrin-B2 controls PDGFRβ internalization and signaling[J].Genes Dev，2013，27(23)：2576-2589.DOI：10.1101/gad.224089.113.
[29]
Du MR, Yan L, Li NS, et al.Asymmetric dimethylarginine contributes to retinal neovascularization of diabetic retinopathy through EphrinB2 pathway[J].Vascul Pharmacol，2018(108)：46-56.DOI：10.1016/j.vph.2018.05.004.
[30]
Li Y, Chen D, Sun L, et al. Induced expression of VEGFC，ANGPT，and EFNB2 and their receptors characterizes neovascularization in proliferative diabetic retinopathy[J].Invest Ophthalmol Vis Sci，2019，60(13)：4084-4096.DOI：10.1167/iovs.19-26767.
[31]
Kaczmarek R, Zimmer K, Gajdzis P, et al.The role of eph receptors and ephrins in corneal physiology and diseases[J].Int J Mol Sci，2021，22(9)：4567.DOI：10.3390/ijms22094567.
[32]
Saito H, Oikawa M, Kouketsu A, et al.Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions[J].Odontology，2020，108(2)：166-173.DOI：10.1007/s10266-019-00466-y.
[33]
Anderton M, van der Meulen E, Blumenthal MJ, et al.The role of the Eph receptor family in tumorigenesis[J].Cancers (Basel)，2021，13(2)：206.DOI：10.3390/cancers13020206.
[34]
Leung HW, Leung C, Lau EY, et al.EPHB2 activates β-Catenin to Enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma[J].Cancer Res，2021，81(12)：3229-3240.DOI：10.1158/0008-5472.CAN-21-0184.
[35]
Wijeratne DT, Rodger J, Wood FM, et al.The role of Eph receptors and Ephrins in the skin[J].Int J Dermatol，2016，55(1)：3-10.DOI：10.1111/ijd.12968.
[36]
张飞，牛瑞芳．EphA2在乳腺癌治疗耐药中作用的研究进展[J].中国肿瘤临床，2021，48(15)：792-796.DOI：10.12354/j.issn.1000-8179.2021.20211104.
[37]
London M, Gallo E．The EphA2 and cancer connection：potential for immune-based interventions[J].Mol Biol Rep，2020，47(10)：8037-8048.DOI：10.1007/s11033-020-05767-y.
[38]
Markosyan N, Li J, Sun YH, et al. Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2)[J].J Clin Invest，2019，129(9)：3594-3609.DOI：10.1172/JCI127755.
[39]
Lau A, Le N, Nguyen C, et al.Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers[J].Cell Signal，2023(104)：110579.DOI：10.1016/j.cellsig.2022.110579.
[40]
Zhao Y, Cai C, Zhang M, et al.Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT[J].J Cancer Res Clin Oncol，2021，147(7)：2013-2023.DOI：10.1007/s00432-021-03618-2.
[41]
Lv XY, Wang J, Huang F, et al.EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells[J].Oncol Rep，2018，40(4)：2408-2416.DOI：10.3892/or.2018.6586.
[42]
Ieguchi K, Maru Y．Roles of EphA1/A2 and ephrin-A1 in cancer[J].Cancer Sci，2019，110(3)：841-848.DOI：10.1111/cas.13942.
[43]
Janes PW, Vail ME, Gan HK, et al. Antibody targeting of Eph receptors in cancer[J].Pharmaceuticals (Basel)，2020，13(5)：88.DOI：10.3390/ph13050088.
[44]
Brantley-Sieders DM, Fang WB, Hicks DJ, et al.Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression[J].FASEB J，2005，19(13)：1884-1886.DOI：10.1096/fj.05-4038fje.
[45]
秦承东，任正刚，汤钊猷．缺氧微环境在肿瘤进展中的作用[J].肿瘤，2016，36(1)：96-102.DOI：10.3781/j.issn.1000-7431.2016.55.563.
[46]
To C, Farnsworth RH, Vail ME, et al.Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth[J].PLoS One，2014，9(11)：e112106.DOI：10.1371/journal.pone.0112106.
[47]
黄波．肿瘤微环境中免疫与炎症的调节[J].中国肿瘤生物治疗杂志，2012，19(2)：111-115.DOI：10.3872/j.issn.1007-385X.2012.02.001.
[48]
Ivanov AI, Romanovsky AA. Putative dual role of ephrin-Eph receptor interactions in inflammation[J].IUBMB Life，2006，58(7)：389-394.DOI：10.1080/15216540600756004.
[49]
Verma A, Gaffen SL, Swidergall M．Innate immunity to mucosal candida infections[J].J Fungi (Basel)，2017，3(4)：60.DOI：10.3390/jof3040060.
[50]
Swidergall M, Solis NV, Wang Z, et al.Epha2 is a neutrophil receptor for candida albicans that stimulates antifungal activity during oropharyngeal infection [J].Cell Rep，2019，28(2)：423-433.e5.DOI：10.1016/j.celrep.2019.06.020.
[51]
Kottom TJ, Schaefbauer K, Carmona EM, et al. Epha2 is a lung epithelial cell receptor for pneumocystis β-glucans [J].J Infect Dis，2022，225(3)：525-530.DOI：10.1093/infdis/jiab384.
[1] 卫怡妙, 李亚芹, 赵卫红. 环状RNA与宫颈癌发病机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 512-516.
[2] 孙珍花, 吴超. 白细胞介素-26在感染性疾病中的研究进展[J]. 中华实验和临床感染病杂志(电子版), 2017, 11(02): 121-124.
[3] 易晨, 黄子贤, 余东升. Hippo信号通路在口腔鳞状细胞癌中的研究进展[J]. 中华口腔医学研究杂志(电子版), 2020, 14(06): 396-400.
[4] 李静超, 欧阳彬. 脑乳酸代谢的特殊性以及其生物学功能的研究进展[J]. 中华重症医学电子杂志, 2018, 04(02): 195-199.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号